-
My Account
In App
My Account
BSE Live
Jan 01, 16:01Prev. Close
1424.05
Open Price
1424.05
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 01, 15:58Prev. Close
1418.90
Open Price
1420.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1398.20 (49)
| Cash Flow of Ipca Laboratories (in Rs. Cr.) | Mar 05 | |
| 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 94.11 | |
| Net CashFlow From Operating Activities | 57.84 | |
| Net Cash Used In Investing Activities | -114.99 | |
| Net Cash Used From Financing Activities | 56.07 | |
| Foreign Exchange Gains / Losses | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -1.08 | |
| Cash And Cash Equivalents Begin of Year | 6.10 | |
| Cash And Cash Equivalents End Of Year | 5.02 |
05.12.2025
26.11.2025
Ipca Labs Consolidated September 2025 Net Sales at Rs 2,556.50 crore, up 8.56% Y-o-Y
24.11.2025
Ipca Labs Standalone September 2025 Net Sales at Rs 1,930.32 crore, up 6.59% Y-o-Y
17.11.2025
26.11.2025
Ipca Labs Consolidated September 2025 Net Sales at Rs 2,556.50 crore, up 8.56% Y-o-Y
24.11.2025
Ipca Labs Standalone September 2025 Net Sales at Rs 1,930.32 crore, up 6.59% Y-o-Y
05.09.2025
Ipca Labs Standalone June 2025 Net Sales at Rs 1,746.90 crore, up 11.56% Y-o-Y
10.06.2025
Ipca Labs Standalone March 2025 Net Sales at Rs 1,638.44 crore, up 8.46% Y-o-Y
13.07.2022
Ipca Lab Q1 PAT may dip 41.4% YoY to Rs 179.8 cr: ICICI Direct
08.07.2022
Ipca Laboratories Q1 PAT may dip 36.5% YoY to Rs 194.9 cr: Prabhudas Lilladher
14.04.2022
Ipca Laboratories Q4 PAT may dip 12% YoY to Rs 141.9 cr: Prabhudas Lilladher
13.01.2022
Ipca Laboratories Q3 PAT may dip 32.4% YoY to Rs 179.6 cr: Prabhudas Lilladher
